Pediatric News

영국에서 B군 수막구균 감염병 예방 접종 백신 4CMenB 으로 3회 접종한 결과 적어도 2년간 접종 효과가 좋았다는 연구 결과가 나왔다. The 4CMenB program was associated with continued positive effect against meningococcal group B disease in children in England, and protection … Continued

B군 수막구균 감염병 예방접종백신 4CMenB접종 결과가 좋다고 한다. The 4CMenB program was associated with continued positive effect against meningococcal group B disease in children in England, and protection after three doses of the vaccine was sustained for at least 2 … Continued

Among Australian adolescents, the 4CMenB vaccine had no discernible effect on the carriage of disease-causing meningococci, including group B. 호주 청소년들 사이에서 4CMenB 백신은 그룹 B를 포함하여 질병을 유발하는 수막구균의 전파에 눈에 띄는 효과가 없었습니다. 소스:January 23, 2020 N Engl … Continued

 헬리코박터필로리 감염과 직계 가족 위암 Helicobacter pylori infection and a family history of gastric cancer January 30, 2020 N Engl J Med 2020; Helicobacter pylori infection and a family history of gastric cancer are the main risk factors for gastric … Continued

폐경기 여성 호르몬 치료 Hormone Therapy for Postmenopausal Women January 30, 2020 N Engl J Med 2020; 여성들에게 폐경기가 오면 일부 여성들에게  얼굴이 화끈거리고 뜨갑고, 밤에 땀이 많이 나고, 피로하고, 수면장애도 생기고, 골다공증,불안감, 스트레스,우울증, 정신 집중이 잘 안되고, 과민하고, 전반적 … Continued

  활성 갑상선 눈 질환 치료에 Teprotumumab Teprotumumab for the Treatment of Active Thyroid Eye Disease   January 23, 2020 N Engl J Med 2020 Among patients with active thyroid eye disease, teprotumumab resulted in better outcomes with respect to proptosis, … Continued

 자살Suicide January 16, 2020 N Engl J Med 2020; Throughout the world, approximately 800,000 people die by suicide every year, accounting for 1.5% of all deaths. Suicide is the 10th leading cause of death in North America and the foremost … Continued

  Harlequin Color Change in a Neonate. 신생아의 할리퀸 색상 변화 List of authors. Gert van den Berg, M.D., Ph.D., and Hanneke Bakker, M.D., Ph.D. January 30, 2020 N Engl J Med 2020; 382:456 DOI: 10.1056/NEJMicm1907713 Harlequin color change is … Continued

Belimumab for systemic lupus erythematosus (SLE), Only one drug for patients with systemic lupus erythematosus (SLE), belimumab, has been approved on the basis of support from a randomized, placebo-controlled trial, and numerous development programs of immunomodulatory treatments have failed to … Continued

Aimmune’s ‘First-Of-Its-Kind’ Peanut Allergy Drug Receives FDA Approval Shanthi Rexaline Benzinga. 에이뮨의 ‘최초’ 땅콩 알레르기 약물, FDA 승인 획득 Shanthi Rexaline Benzinga Aimmune’s ‘First-Of-Its-Kind’ Peanut Allergy Drug Receives FDA Approval Shanthi Rexaline BenzingaFebruary 1, 2020, 3:53 PM EST